MBBS, Urology Registrar, Princess Alexandra Hospital, The University of Queensland, Brisbane, Qld.
MBSS, PhD, FRACS, Consultant Urologist, Princess Alexandra Hospital, The University of Queensland, Brisbane, Qld.
Aust J Gen Pract. 2024 Oct;53(10):773-776. doi: 10.31128/AJGP-02-24-7141.
Treatment for prostate cancer (PC) is associated with adverse effects, especially in patients receiving androgen deprivation therapy (ADT). The Australian Government, non-governmental organisations and pharmaceutical companies responsible for marketing ADT have initiated and sponsored various strategic support programs for patients diagnosed with PC.
This professional article provides an overview of available PC patient support programs in Australia to assist general practitioners (GPs) to direct patient referrals and optimise clinical care.
These PC support programs provide useful assistance on educational materials, decision support, clinical care management and referral to specialised services (eg continence advice, sexual health counselling and psychological support). More concerted efforts and smarter investment in PC survivorship programs are necessary to engage, educate and improve the lives of men living with PC more effectively.
前列腺癌（PC）的治疗方法会产生不良反应，尤其是接受雄激素剥夺疗法（ADT）的患者。澳大利亚政府、负责 ADT 营销的非政府组织和制药公司为确诊患有 PC 的患者发起并赞助了各种战略支持计划。
本文概述了澳大利亚现有的 PC 患者支持计划，旨在帮助全科医生（GP）为患者提供转介服务，并优化临床护理。
这些 PC 支持计划提供了有用的教育材料、决策支持、临床护理管理以及转介至专科服务（如控尿建议、性健康咨询和心理支持）。需要更加协调一致地努力，更加明智地投资于 PC 生存者计划，以更有效地吸引、教育和改善 PC 患者的生活。
